ATP6V1H and osteoporosis: In any event, the bone defect caused by atp6v1h deficiency through activation of mmp9/13 represents a novel finding that offers potential therapeutic entry points for related diseases, since MMP9 levels have been correlated to severity of osteoporosis [32].